当前位置:首页 - 行情中心 - 派林生物(000403) - 财务分析 - 资产负债表

派林生物

(000403)

  

流通市值:91.34亿  总市值:92.28亿
流通股本:9.41亿   总股本:9.50亿

资产负债表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
流动资产:
  货币资金530,726,194.23812,182,344.91435,528,823.24770,157,845.79
  交易性金融资产445,940,174.01259,798,438.09263,710,458.99254,385,624.02
  应收票据及应收账款716,400,503.28780,442,710.55894,841,729.26993,236,448.42
  其中:应收票据31,335,747.2725,963,022.0851,970,751.1563,652,615
        应收账款685,064,756.01754,479,688.47842,870,978.11929,583,833.42
  应收款项融资91,115,819.6678,778,105.671,766,670.9495,813,656.31
  预付款项24,081,351.4634,090,898.3437,985,469.1530,002,643.69
  其他应收款合计5,628,561.969,156,528.968,438,091.516,199,122.68
  其中:应收利息1,232,876.691,265,753.411,222,862.341,627,397.26
  存货1,926,384,231.841,903,508,244.851,791,792,488.491,563,473,838.46
  其他流动资产28,328,755.8336,691,650.6846,155,919.497,739,008.61
  流动资产合计3,768,605,592.273,914,648,921.983,550,219,651.073,721,008,187.98
非流动资产:
  长期应收款750,000,000750,000,000700,000,000600,000,000
  投资性房地产254,914.55262,034.51269,154.47276,274.43
  固定资产1,768,504,157.721,765,906,542.291,800,351,644.931,830,901,713.42
  在建工程272,502,434.37246,429,868.82231,945,598.59225,989,115.26
  使用权资产16,303,025.1617,246,422.814,195,758.9915,275,418.19
  无形资产176,724,303.4181,476,951.28187,162,788.55190,219,726.57
  开发支出225,042,300.98204,557,784.14190,125,957.45178,059,750.53
  商誉2,536,010,097.282,536,010,097.282,536,010,097.282,536,010,097.28
  长期待摊费用53,004,808.6851,071,66551,505,294.0151,841,247.63
  递延所得税资产25,777,975.4624,985,301.6427,276,221.6726,581,647.02
  其他非流动资产71,942,581.1992,083,623.3493,655,039.2890,185,897.89
  非流动资产合计5,896,066,598.795,870,030,291.15,832,497,555.225,745,340,888.22
  资产总计9,664,672,191.069,784,679,213.089,382,717,206.299,466,349,076.2
流动负债:
  短期借款581,344,445.66741,387,514.5536,310,337.48535,704,305.56
  应付票据及应付账款238,942,552.25206,182,416.15133,710,869.43155,259,545.5
  其中:应付票据63,670,568.9552,537,043.45-3,984,757.6
        应付账款175,271,983.3153,645,372.7133,710,869.43151,274,787.9
  合同负债3,124,780.643,896,443.843,690,882.363,043,419.73
  应付职工薪酬23,321,322.8319,908,820.7435,326,806.8671,291,944.33
  应交税费26,028,512.1923,698,264.6436,169,463.4143,306,950.65
  其他应付款合计336,092,679.45201,828,478.94216,518,549.88229,424,012.49
        应付股利141,789,527.941,093,534.431,093,534.431,093,534.43
  一年内到期的非流动负债58,718,962.6578,832,934.3475,132,243.6471,590,753.94
  其他流动负债17,975,826.810,770,277.3115,787,935.6118,862,471.82
  流动负债合计1,285,549,082.471,286,505,150.461,052,647,088.671,128,483,404.02
非流动负债:
  长期借款344,872,090.48375,990,195.67161,848,541.66193,828,468.4
  租赁负债12,834,334.6913,556,561.9513,802,205.111,939,656.66
  递延收益55,976,772.9946,986,662.1337,483,900.2936,973,979.73
  递延所得税负债11,582,017.8511,494,304.1112,964,962.1213,874,638.62
  非流动负债合计425,265,216.01448,027,723.86226,099,609.17256,616,743.41
  负债合计1,710,814,298.481,734,532,874.321,278,746,697.841,385,100,147.43
所有者权益(或股东权益):
  实收资本(或股本)950,397,386950,397,386950,397,386950,397,386
  资本公积4,538,892,789.164,538,892,789.164,538,892,789.164,538,892,789.16
  减:库存股138,238,632.1116,056,433.37--
  其他综合收益14,303.2921,085.5130,865.0240,832.74
  盈余公积178,136,512.88178,136,512.88177,313,391.27177,313,391.27
  未分配利润2,430,168,052.32,504,860,906.632,444,351,904.62,421,383,071.4
  归属于母公司股东权益合计7,959,370,411.538,056,252,246.818,110,986,336.058,088,027,470.57
  少数股东权益-5,512,518.95-6,105,908.05-7,015,827.6-6,778,541.8
  股东权益合计7,953,857,892.588,050,146,338.768,103,970,508.458,081,248,928.77
  负债和股东权益合计9,664,672,191.069,784,679,213.089,382,717,206.299,466,349,076.2
公告日期2026-10-222026-08-242026-04-292026-04-29
审计意见(境内)标准无保留意见
TOP↑